Mascoma Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $543K | Sell |
1,084
-19
| -2% | -$9.12K | 0.1% | 56 |
|
|
2026
Q1 | $542K | Buy |
1,103
+4
| +0.4% | +$2.17K | 0.11% | 55 |
|
|
2025
Q4 | $637K | Sell |
1,099
-21
| -2% | -$11.9K | 0.14% | 49 |
|
|
2025
Q3 | $543K | Sell |
1,120
-14
| -1% | -$6.52K | 0.12% | 54 |
|
|
2025
Q2 | $460K | Sell |
1,134
-102
| -8% | -$42.6K | 0.11% | 57 |
|
|
2025
Q1 | $615K | Buy |
1,236
+200
| +19% | +$108K | 0.15% | 48 |
|
|
2024
Q4 | $539K | Buy |
1,036
+14
| +1% | +$7.7K | 0.14% | 49 |
|
|
2024
Q3 | $632K | Hold |
1,022
| – | – | 0.16% | 46 |
|
|
2024
Q2 | $565K | Hold |
1,022
| – | – | 0.15% | 48 |
|
|
2024
Q1 | $594K | Hold |
1,022
| – | – | 0.17% | 46 |
|
|
2023
Q4 | $542K | Sell |
1,022
-33
| -3% | -$16K | 0.16% | 52 |
|
|
2023
Q3 | $534K | Buy |
1,055
+184
| +21% | +$98K | 0.17% | 54 |
|
|
2023
Q2 | $484K | Sell |
871
-171
| -16% | -$92.3K | 0.15% | 60 |
|
|
2023
Q1 | $578K | Sell |
1,042
-29
| -3% | -$16.3K | 0.17% | 59 |
|
|
2022
Q4 | $590K | Buy |
1,071
+3
| +0.3% | +$1.59K | 0.19% | 59 |
|
|
2022
Q3 | $542K | Sell |
1,068
-16
| -1% | -$8.95K | 0.19% | 63 |
|
|
2022
Q2 | $589K | Buy |
1,084
+48
| +5% | +$26.4K | 0.2% | 62 |
|
|
2022
Q1 | $612K | Buy |
1,036
+99
| +11% | +$56.9K | 0.19% | 66 |
|
|
2021
Q4 | $625K | Buy |
937
+94
| +11% | +$58.7K | 0.22% | 56 |
|
|
2021
Q3 | $482K | Hold |
843
| – | – | 0.19% | 60 |
|
|
2021
Q2 | $425K | Buy |
843
+16
| +2% | +$7.55K | 0.18% | 67 |
|
|
2021
Q1 | $377K | Buy |
+827
| New | +$395K | 0.16% | 72 |
|
|
2019
Q3 | – | Sell |
-125
| Closed | -$37K | – | 306 |
|
|
2019
Q2 | $37K | Sell |
125
-5
| -4% | -$1.38K | 0.02% | 178 |
|
|
2019
Q1 | $36K | Hold |
130
| – | – | 0.02% | 173 |
|
|
2018
Q4 | $29K | Hold |
130
| – | – | 0.02% | 176 |
|
|
2018
Q3 | $32K | Hold |
130
| – | – | 0.02% | 197 |
|
|
2018
Q2 | $27K | Buy |
130
+5
| +4% | +$1.06K | 0.02% | 201 |
|
|
2018
Q1 | $26K | Hold |
125
| – | – | 0.02% | 200 |
|
|
2017
Q4 | $27K | Sell |
125
-3
| -2% | -$575 | 0.02% | 191 |
|
|
2017
Q3 | $24K | Sell |
128
-3
| -2% | -$543 | 0.02% | 211 |
|
|
2017
Q2 | $23K | Buy |
131
+6
| +5% | +$1.01K | 0.02% | 225 |
|
|
2017
Q1 | $19K | Hold |
125
| – | – | 0.01% | 223 |
|
|
2016
Q4 | $18K | Buy |
+125
| New | +$18.4K | 0.01% | 229 |
|
Other funds holding TMO
Mascoma Wealth Management's TMO Position: Q2 2026 in Review
Mascoma Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 1.7% in Q2 2026, selling an estimated $9.12K and leaving 1,084 shares worth $543K. The position accounts for 0.1% of the portfolio, ranked #56.
Mascoma Wealth Management first reported a position in TMO in Q4 2016 and has held it in 33 quarters since. The position peaked at $637K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Mascoma Wealth Management held 1,084 shares of Thermo Fisher Scientific worth $543K as of Q2 2026.
- Mascoma Wealth Management sold 19 Thermo Fisher Scientific shares in Q2 2026, an estimated $9.12K.
- Thermo Fisher Scientific made up 0.1% of Mascoma Wealth Management's portfolio in Q2 2026, its #56 holding.
- Mascoma Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 33 quarters since.
- Mascoma Wealth Management's Thermo Fisher Scientific position peaked at $637K in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.